The OHBP is proud to have contributed to this new research led by the Pharma Pollution Hub providing a roadmap for high-income countries to transform the way they supply, use and dispose of pharmaceuticals. The UK case study highlights the complexity, resilience, and unsustainability of the current UK health care pharmaceutical system, and the need for systems-based mitigation strategies. The proposed strategy is envisioned to support stakeholders from across the pharmaceutical lifecycle to enact transformational change in moving to a system which mitigates the public and environmental risks of pharmaceutical pollution while maintaining the important benefits that medicines bring us.
Overarching strategy for transformational change in mitigating the public and environmental risks of pharmaceutical pollution from health care in high-income countries
Co-authors include OHBP members from NHS Highland, SEPA, and the Environmental Research Institute (University of the Highlands and Islands). The OHBP members participated in the transdisciplinary consortium of 48 stakeholders from across the UK pharmaceutical lifecycle to identify the 37 intervention points underpinning the proposed systems-based strategy to address pharmaceutical pollution.
See the press release on the Pharma Pollution Hub’s website:
The full article can be found here:
The Pharma Pollution Hub & OHBP
The Pharma Pollution Hub is a new independent change hub and registered charity that is working with organisations across the pharmaceutical life cycle to transform the way our society produces, uses and disposes of medicines. The OHBP have supported the co-development of the Pharma Pollution Hub since 2021, including participating in the Strategic Advisory Group and Board of Trustees, as well as through through consortium membership and working group (Environmental Monitoring and Management) leadership.